Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q2 FY22 results · Jul–Sep 2021
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,058.30 crore (up 4.8% from Q2 FY21) and net profit of ₹218.29 crore (down 14.0% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,058.30 | 1,009.45 | +4.8% | 786.59 | +34.5% |
| Other income | 5.80 | 9.56 | −39.3% | 5.72 | +1.4% |
| Total income | 1,064.10 | 1,019.01 | +4.4% | 792.31 | +34.3% |
| Profit before tax | 293.84 | 335.70 | −12.5% | 67.25 | +336.9% |
| Net profit for the period | 218.29 | 253.86 | −14.0% | 48.98 | +345.7% |
| EPS, basic (₹) | 67.25 | 78.21 | −14.0% | 15.09 | +345.7% |
| Net margin (%) | 20.6 | 25.1 | 6.2 |
Standalone
- Filed with BSE
- 02 Nov 2021, 18:05 IST
- Board meeting
- 02 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE